Allergan plc
Analyst Listing
The following analysts provide coverage for the subject firm as of May 2016:
Primary Input Data
Derived Input Data
Derived Input |
Label |
2015 Value |
2016
|
Equational Form |
Net Operating Profit Less Adjusted Taxes | NOPLAT | (709) | (564) | |
Free Cash Flow | FCF | 4,075 | 1,094 | |
Tax Shield | TS | 77 | 866 | |
Invested Capital | IC | 127,512 | 121,111 | |
Return on Invested Capital | ROIC | -0.56% | -0.47% | |
Net Investment | NetInv | 85,584 | 223 | |
Investment Rate | IR | -12,068.43% | -39.49% | |
Weighted Average Cost of Capital |
WACCMarket | 41.26% | 26.68% | |
WACCBook | 7.37% | 6.45% | ||
Enterprise value |
EVMarket | 166,087 | 97,354 | |
EVBook | 164,050 | 94,820 | ||
Long-Run Growth |
g = IR x ROIC |
67.12% | 0.18% | Long-run growth rates of the income variable are used in the Continuing Value portion of the valuation models. |
g = % |
2.50% | 2.50% | ||
Margin from Operations | M | -5.54% | -4.56% | |
Depreciation/Amortization Rate | D | 117.57% | 111.14% |
Valuation Multiple Outcomes
The outcomes presented in this study are the result of original input data, derived data, and synthesized inputs.
Equational Form |
Observed Value |
Single-stagemultiple g solution |
Two-stage valuationmodel g solution |
|||
12/31/2015 | 12/31/2016 | 12/31/2015 | 12/31/2016 | 12/31/2015 | 12/31/2016 | |
|
11.02 |
6.68 | 179.49% | -111.69% | 48.66% | 43.41% |
|
34.98 |
16.33 | 179.49% | -111.69% | 48.66% | 43.41% |
|
-234.20 |
-172.49 | 179.49% | -111.69% | 48.66% | 43.41% |
|
40.76 |
89.00 | 179.49% | -111.69% | 48.66% | 43.41% |
|
-199.07 |
-146.62 | 179.49% | -111.69% | 48.66% | 43.41% |
|
1.30 |
0.80 | 179.49% | -111.69% | 48.66% | 43.41% |